Methylamine

Methylamine

SCHEMBL28040222

CN.CN.CN.c1ccc(CCN2CCOCC2)cc1

nearest known ligand 0.72

Full drug profile on Sugi Atlas →

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 4/20 0.72
POLB P06746 1/20 0.72
SLC6A3 Q01959 1/20 0.61
HTR1A P08908 1/20 0.59
DRD2 P14416 1/20 0.59
ACHE P22303 1/20 0.57
KMT2A Q03164 2/20 0.56
MEN1 O00255 1/20 0.56
MAPT P10636 1/20 0.55
NPSR1 Q6W5P4 1/20 0.55
ALDH1A1 P00352 1/20 0.54
HTT P42858 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9539677 0.94 SIGMAR1 (0.79) SIGMAR1POLBSLC6A3HTR1ADRD2
SCHEMBL78043 0.94 SIGMAR1 (0.79) SIGMAR1POLBSLC6A3HTR1ADRD2
Ethylene SCHEMBL28207535 0.91 SIGMAR1 (0.74) SIGMAR1POLBSLC6A3HTR1ADRD2
Isothiocyanate SCHEMBL2892892 0.85 SIGMAR1 (0.66) SIGMAR1POLBSLC6A3HTR1ADRD2
SCHEMBL21465700 0.84 SIGMAR1 (0.65) SIGMAR1POLBSLC6A3HTR1ADRD2
SCHEMBL1711070 0.84 SIGMAR1 (1.00) SIGMAR1POLBKMT2AHTT
SCHEMBL27701997 0.84 SIGMAR1 (0.64) SIGMAR1POLBSLC6A3HTR1ADRD2
Sulfurous Acid SCHEMBL27938413 0.83 SIGMAR1 (0.64) SIGMAR1POLBSLC6A3HTR1ADRD2
SCHEMBL4425957 0.82 SIGMAR1 (0.90) SIGMAR1POLBKMT2AMEN1HTT
SCHEMBL13150782 0.80 SLC6A3 (0.83) SIGMAR1SLC6A3HTR1ADRD2ACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105431428-A Substituted benzoxazoles Bayer Pharma AG 2016-03-23 CN disclosed
CN-105408331-A Triazolopyridines as thrombin inhibitors for the treatment of thromboembolic disorders Bayer Pharma AG 2016-03-16 CN disclosed